BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6195403)

  • 1. [Immunologic and cytochemical characteristics of the cellular substrate in lymphoproliferative diseases].
    Soboleva TN
    Lab Delo; 1983; (8):3-7. PubMed ID: 6195403
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal immunoglobulins and B cell lymphoproliferative disorders.
    Sugai S; Takiguchi T; Konda S
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1604-15. PubMed ID: 6335808
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation.
    Novoa-Takara L; Dincer A; Kampalath B; Van Tuinen P; Hariharan S; Chang C
    Histopathology; 2005 Sep; 47(3):333-4. PubMed ID: 16115242
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of immunologic markers in obscure hematologic disease.
    Miller CH; Mann S; Hamersley J; Glassy FJ; O'Grady LF
    West J Med; 1983 Oct; 139(4):475-9. PubMed ID: 6580780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new peak in the ALPS.
    Fischer A; Rieux-Laucat F; Le Deist F
    Nat Med; 1999 Aug; 5(8):876-7. PubMed ID: 10426307
    [No Abstract]   [Full Text] [Related]  

  • 8. Gamma (immune) interferon produced by leukocytes from a patients with a T cell proliferation disease.
    Hooks JJ; Haynes BF; Detrick-Hooks B; Diehl LF; Gerrard TL; Fauci AS
    Trans Assoc Am Physicians; 1981; 94():198-203. PubMed ID: 6178202
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoglobulins in lymphoproliferative diseases. I. A study of serum and surface immunoglobulins in chronic lympholeukemia].
    Kharchenko MF; Moiseeva VP; Khodzhakulieva AM; Rybakova LP; Rozanova LM
    Zdravookhr Kirg; 1980; (1):34-8. PubMed ID: 6103611
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistological analysis of bone marrow involvement in lymphoproliferative disorders. The use of cryostat sections from trephine biopsies.
    Pizzolo G; Chilosi M; Fiore-Donati L; Janossy G
    Haematologia (Budap); 1984; 17(2):247-57. PubMed ID: 6398792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-surface markers in lymphoproliferative disease.
    N Engl J Med; 1981 May; 304(21):1302-4. PubMed ID: 7219481
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum and surface immunoglobulin studies in the diagnosis of lymphoproliferative diseases].
    Kharchenko MF; Moiseeva VP; Khodzhakulieva AM; Gal'perina IIu; Rybakova LP
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):7-11. PubMed ID: 7301792
    [No Abstract]   [Full Text] [Related]  

  • 13. A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders.
    Pizzolo G; Ambrosetti A; Rossetti G; Zampini LS; Menestrina F; Chilosi M; Perona G
    Haematologica; 1982 Oct; 67(5):710-7. PubMed ID: 6816683
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous post-transplant lymphoproliferative disorder with atypical Hodgkin and Reed-Sternberg-like cells.
    Robinson C; Burroughs S; Addis B; Mason J
    Histopathology; 2007 Feb; 50(3):403-4. PubMed ID: 17257146
    [No Abstract]   [Full Text] [Related]  

  • 15. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic diagnosis of variants of chronic lymphoid leukemia and lymphosarcomas].
    Samoĭlova RS; Ol'shevskaia EV; Polianskaia AM
    Ter Arkh; 1981; 53(11):73-8. PubMed ID: 7041315
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of human B cell tumor growth in SCID mice by monoclonal anti-B cell antibodies.
    Durandy A; Brousse N; Rozenberg F; De Saint Basile G; Fischer AM; Fischer A
    Immunodeficiency; 1993; 4(1-4):73-6. PubMed ID: 8167739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possible effects of chronic lymphoproliferative diseases and pre-dialytic uremic states on cellular immunity. Their importance in anesthesiology].
    Celleno D; Consoli P; Ghelli A; Emanuelli M
    Minerva Anestesiol; 1981 Aug; 47(8):455-66. PubMed ID: 7031505
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorder.
    Khatri VP; Baiocchi RA; Peng R; Oberkircher AR; Dolce JM; Ward PM; Herzig GP; Caligiuri MA
    J Immunol; 1999 Jul; 163(1):500-6. PubMed ID: 10384154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acid nonspecific esterase in lymphoproliferative conditions].
    Hermanský F; Benesová E; Lodrová V; Sálková J
    Vnitr Lek; 1979 May; 25(5):436-42. PubMed ID: 452428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.